{"schema_version":"secwatch.filing_event.v1","accession":"0001818382-23-000037","form_type":"8-K","ticker":"HUMA","cik":"0001818382","company_name":"Humacyte, Inc.","filed_at":"2023-06-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.821716+00:00","generated_at":"2026-06-14T05:11:21.134072+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Humacyte stockholders elect directors and ratify PwC as auditor at 2023 annual meeting","bullets":["Elected Gordon Binder, Todd Pope, Kathleen Sebelius, Rajiv Shukla as Class II directors (term to 2026).","Ratified PricewaterhouseCoopers LLP as independent auditor for FY2023: 61,686,786 for, 59,411 against.","Quorum of 61,760,774 shares (59.8% of outstanding) present at June 7, 2023 meeting.","Broker non-votes of 8,073,222 on director election; none on auditor ratification."],"urls":{"canonical":"https://secwatch.observer/filing/0001818382-23-000037","json":"https://secwatch.observer/filing/0001818382-23-000037.json","markdown":"https://secwatch.observer/filing/0001818382-23-000037.md","text":"https://secwatch.observer/filing/0001818382-23-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818382/000181838223000037/0001818382-23-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818382/000181838223000037/huma-20230607.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T05:11:21.134072+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ab335725fd276ab2fb9c1aeb4910d9972428a13","claim":"Humacyte, Inc. shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2023-06-07 meeting.","evidence_excerpt":"Proposal 2 – Ratification of the Selection of Independent Registered Public Accounting Firm. The appointment of Pricewaterhouse Coopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023 was ratified. The results of stockholders’ votes on this matter were as follows: For Against Abstain 61,686,786 59,411 14,577 There were no broker non-votes on this proposal.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838223000037/0001818382-23-000037-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"},{"claim_id":"8e1596c7fa3592bd37c5e463f4b311a1b16d4808","claim":"Humacyte, Inc. shareholders approved Election of Class II Directors at the 2023-06-07 meeting.","evidence_excerpt":"The stockholders elected each of the four Class II directors who were nominated to serve until the Company’s 2026 annual meeting of stockholders or until such director’s successor is elected, or until such director’s earlier death, resignation or removal. The results of stockholders’ votes on this matter were as follows: Nominee For Withheld Broker Non-Votes Gordon M. Binder 53,072,579 614,973 8,073,222 Todd M. Pope 53,537,054 150,498 8,073,222 Kathleen Sebelius 49,175,215 4,512,337 8,073,222 Rajiv Shukla 52,859,609 827,943 8,073,222","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818382/000181838223000037/0001818382-23-000037-index.htm","confidence":0.99,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-07"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}